|  | 市場調查報告書 商品編碼 1828048 2025年低溫恒溫器全球市場報告Cryostat Global Market Report 2025 | ||||||
近年來,低溫恒溫器市場穩定成長,預計2024年將達25.6億美元,2025年將達26.8億美元,複合年成長率為4.7%。預測期內的成長可歸因於生物醫學研究的擴展、低溫電子顯微鏡(cryo-EM)的興起、生物樣本庫和生物檢體資料庫的發展、癌症研究和診斷、藥物研發、組織工程的進步以及人體冷凍服務的興起。
預計未來幾年低溫恒溫器市場規模將強勁成長,2029年將達36.1億美元,複合年成長率為7.7%。預測期內的成長歸因於諸多因素,例如其在製藥製造業中的作用日益增強、基因組學研究的重要性日益提升、生物樣本庫活動的全球擴張、藥品品管、向照護現場診斷的轉變以及低溫儲存系統的進步。預測期內的主要趨勢包括低溫技術的進步、成像技術的創新、與人工智慧的融合、研發合作以及奈米技術的應用。
低溫低溫恒溫器是醫療設備,用於將組織切片保持在恆定的低溫下,將其切成薄片進行顯微鏡檢查,並有助於診斷各種疾病和病症。它有助於保存冷凍的組織樣本。
低溫恒溫器的主要類型包括閉循環低溫恒溫器、連續流低溫恒溫器、恆溫槽低溫恒溫器和多級低溫恒溫器。封閉式循環低溫恒溫器是一種無氦系統,無需使用傳統致冷劑即可冷卻至液態氦溫度。系統組件包括杜瓦瓶、轉移管、氣流泵、溫度控制器、高真空幫浦和微調葉片,並使用多種致冷劑,包括氦氣和氮氣。低溫恒溫器廣泛應用於醫療保健、能源電力、航空、冶金、生物技術、法醫學和海洋生物學等多個產業。
2025年春季,美國關稅飆升及其引發的貿易摩擦醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰進一步加劇了情況的複雜化,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準產品的國內生產以及加快研發更具成本效益的材料來降低風險。
本研究報告是商業研究公司(The Business Research Company)最新發布的低溫恒溫器器光學市場統計數據報告之一,涵蓋低溫恒溫器低溫恒溫器器光學行業的全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的低溫恒溫器光學細分市場、市場趨勢和商業機會,以及在低溫恒溫器恆溫器光學行業取得成功所需的數據。低溫恒溫器光學市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供全面的觀點。
未來五年7.7%的預測成長率,較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這一影響將直接影響美國,導致來自義大利和英國等主要地區的切片機刀片組件和精密溫控模組供應鏈中斷,可能導致病理診斷延遲和組織學實驗室成本增加。此外,由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這項影響也將更加廣泛。
預計神經肌肉疾病盛行率的不斷上升將推動未來低溫恒溫器市場的成長。神經肌肉疾病包括影響周邊神經系統的疾病,通常導致進行性肌肉無力這種顯著症狀。這些疾病盛行率的不斷上升推動了對低溫恒溫器的需求,因為低溫恒溫器在快速診斷各種疾病(包括神經肌肉疾病)中發揮關鍵作用。例如,2022 年 12 月,專注於肌肉骨骼損傷預防培訓和諮詢的英國公司 Osteopaths For Industry Ltd. 報告稱,2021 年至 2022 年期間有 477,000 例與工作相關的肌肉骨骼疾病病例。此外,2022 年 7 月,世界衛生組織 (WHO) 指出,全球約有 17.1 億人患有肌肉骨骼疾病。因此,神經肌肉疾病盛行率的不斷上升正在推動低溫恒溫器市場的成長。
感染疾病的激增是低溫恒溫器市場崛起的主要原因。由病毒、細菌、真菌和寄生蟲等各種病原體引起的感染疾病正變得越來越普遍。由於處理此類病原體存在潛在風險,因此在感染疾病管理中使用低溫恒溫器至關重要。組織檢體通常含有傳染性物質,需要特別處理,尤其是某些疾病檢體呈陽性的個體的樣本。例如,根據英國國家統計局的統計數據,截至 2022 年 12 月 9 日當週,感染率呈上升趨勢,35 至 69 歲人口的感染率達到 1.92%,12 至 24 歲學齡人口的感染率達到 1.25%。因此,感染疾病的傳播預計將推動低溫恒溫器市場的擴張。
低溫恒溫器市場的主要企業正在開發創新產品,例如氦回收解決方案,旨在提高永續性、降低營運成本並提高低溫系統的效率。氦回收解決方案是專門設計用於回收、再循環和再利用氦氣的系統,氦氣是一種廣泛用於低溫恒溫器等低溫應用的寶貴且有限的資源。例如,2024 年 4 月,英國低溫測量系統製造商 Bluefors 推出了 Cryomech HeRL02-RM。這種專門的氦回收解決方案針對單一核磁共振 (NMR) 系統。 HeRL02-RM 建立了一個閉合迴路系統,可從 NMR 磁鐵中回收沸騰的氦氣,將其透過蒸汽回流管線引導至脈管低溫冷凍機驅動的液化器,在那裡氦氣被迅速液化並返回到磁鐵的氦浴中。
低溫恒溫器市場的主要參與企業正在推進零沸騰 (ZBO) 等技術,以最大限度地減少低溫流體損失、提高系統效率並降低維護成本。 ZBO 技術可防止液態氦和液態氮等低溫流體的蒸發和損失,這些流體容易因溫度變化而沸騰。例如,2023 年 4 月,印度低溫工程公司 INOXCVA 成功製造了印度首台自主設計的 4K 氦低溫低溫恒溫器,用於全身 1.5T超導性MRI 磁體系統。此低溫恒溫器採用零沸騰技術,顯著減少了運作過程中的氦氣損失,提高了效率和成本效益。
2022年8月,總部位於瑞典的跨國工業公司阿特拉斯·科普柯完成了對蒙大拿儀器公司的收購,具體金額未披露。此次策略性收購預計將顯著拓展阿特拉斯科普柯在低溫領域的現有業務,並加強其與研發客戶的關係。此外,此次收購也為阿特拉斯·科普柯進入新興量子技術相關市場提供了新的途徑,這些市場的商業應用正逐漸普及。蒙大拿儀器公司以其在低溫恒溫器製造領域的專業知識而聞名,透過此次收購,該公司已成為阿特拉斯科普柯投資組合的一部分。
低溫恒溫器市場包括單壓縮機、雙壓縮機、旋轉式低溫恒溫器和電動低溫恒溫器的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場的商品價值還包括商品製造商銷售的任何相關服務。低溫恒溫器市場細分為單壓縮機、雙壓縮機、旋轉式低溫恒溫器和其他低溫恒溫器。
A cryostat is a medical equipment designed to maintain tissue sections at a constant low temperature and slice them into thin sections for microscopic examination, facilitating the diagnosis of various diseases and ailments. It is instrumental in preserving frozen tissue samples.
The major types of cryostats include closed-cycle cryostats, continuous-flow cryostats, bath cryostats, and multistage cryostats. Closed-cycle cryostats are helium-free systems that enable cooling down to liquid helium temperatures without the use of traditional cryogens. The components of the system include dewars, transfer tubes, gas flow pumps, temperature controllers, high vacuum pumps, and microtone blades, with various cryogens such as helium and nitrogen. Cryostats find applications in various industries, including healthcare, energy and power, aeronautics, metallurgy, biotechnology, forensic science, and marine biology.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The cryostats market research report is one of a series of new reports from The Business Research Company that provides cryostats optical components market statistics, including cryostats optical components industry global market size, regional shares, competitors with a cryostats optical components market share, detailed cryostats optical components market segments, market trends and opportunities, and any further data you may need to thrive in the cryostats optical components industry. The cryostats optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cryostat market size has grown steadily in recent years. It will grow from $2.56 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to expansion of biomedical research, rise of cryo-electron microscopy (cryo-EM), biobanking and biorepository development, cancer research and diagnostics, drug discovery and development, tissue engineering advancements, increase in cryonics services.
The cryostat market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to expanding role in drug manufacturing, growing importance of genomic research, global expansion of biobanking activities, quality control in pharmaceuticals, shift towards point-of-care diagnostics, advancements in cryogenic storage systems. Major trends in the forecast period include advancements in cryogenic technologies, technological innovations in imaging, integration with artificial intelligence, collaborations for research and development, applications in nanotechnology.
The forecast of 7.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microtome blade assemblies and precision temperature control modules, sourced from key regions such as Italy and the UK, which could lead to delayed pathology diagnoses and increased histology laboratory costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of neuromuscular diseases is projected to drive growth in the cryostat market in the future. Neuromuscular diseases encompass conditions that affect the peripheral nervous system, often leading to progressive muscle weakness as a significant symptom. Cryostats play a crucial role in providing rapid diagnoses for various illnesses, including neuromuscular disorders, thus elevating the demand for cryostats in response to the rising incidence of these diseases. For instance, in December 2022, Osteopaths For Industry Ltd., a UK-based company focused on musculoskeletal injury prevention training and consultancy, reported 477,000 cases of work-related musculoskeletal disorders for the 2021-2022 period. Moreover, in July 2022, the World Health Organization indicated that approximately 1.71 billion people globally suffer from musculoskeletal disorders. Consequently, the increasing prevalence of neuromuscular diseases is driving the growth of the cryostat market.
The upsurge in infectious diseases is significantly contributing to the upward trajectory of the cryostat market. Infectious diseases, stemming from various pathogens such as viruses, bacteria, fungi, or parasites, are increasingly common. The utilization of cryostats in managing infectious diseases is crucial due to the potential risks associated with handling such agents. Tissue samples often contain infectious agents, necessitating specialized handling, particularly for samples from individuals positive for certain diseases. For instance, statistics from the Office for National Statistics in the UK indicated an escalating infection rate by the week ending December 9, 2022, notably reaching 1.92% among individuals aged 35 to 69 years and 1.25% in school years 12 to 24. Hence, the mounting prevalence of infectious diseases is anticipated to fuel the expansion of the cryostat market.
Leading companies in the cryostat market are developing innovative products, such as helium recovery solutions, aimed at enhancing sustainability, lowering operational costs, and improving the efficiency of cryogenic systems. Helium recovery solutions are systems specifically designed to capture, recycle, and reuse helium, a precious and limited resource widely used in cryogenic applications like cryostats. For example, in April 2024, Bluefors, a UK-based manufacturer of cryogenic measurement systems, launched the Cryomech HeRL02-RM. This specialized helium recovery solution is intended for single Nuclear Magnetic Resonance (NMR) systems. The HeRL02-RM establishes a closed-loop system that captures boiled-off helium from NMR magnets, redirecting it through a vapor return line to a Pulse Tube Cryocooler-powered liquefier, where it is rapidly liquefied and returned to the magnet's helium bath.
Key players in the cryostat market are advancing technologies like zero-boil-off (ZBO) technology to minimize the loss of cryogenic fluids, enhance system efficiency, and lower maintenance costs. ZBO technology is designed to prevent the evaporation or loss of cryogenic fluids, such as liquid helium or liquid nitrogen, which tend to boil off due to temperature variations. For instance, in April 2023, INOXCVA, an India-based cryogenic engineering company, successfully manufactured India's first indigenously designed 4K helium cryostat for a whole-body 1.5T superconducting MRI magnet system. This cryostat incorporates zero-boil-off technology, significantly reducing helium loss during operation, thus making it more efficient and cost-effective.
In August 2022, Atlas Copco, a multinational industrial company based in Sweden, completed the acquisition of Montana Instruments Corporation for an undisclosed sum. This strategic acquisition is expected to significantly expand Atlas Copco's existing footprint in the cryogenic markets and strengthen its relationships with research and development customers. Moreover, it provides an additional avenue for Atlas Copco to penetrate emerging quantum technology-related markets, where commercial applications are progressively gaining traction. Montana Instruments Corporation, renowned for its expertise in cryostat manufacturing, became a part of Atlas Copco's portfolio through this acquisition.
Major companies operating in the cryostat market include Lake Shore Cryotronics Inc, Cryomech Inc, Epredia, Hacker Instruments & Industries Inc, Histo-Line Laboratories Srl, Jinhua YIDI Medical Appliance Co Ltd, SLEE Medical GmbH, Leica Biosystems, Lupetec Technologies, MEDITE Medical GmbH, Boeckeler Instruments Inc, Bright Instruments Ltd, Precision Cryogenics Systems Inc, Atico Medical Pvt Ltd, Biobase Biodusty Co Ltd, Cryofab Inc., Amos Scientific, Thermo Fisher Scientific Inc., Oxford Instruments, Star Cryoelectronics, Infrared laboratories, Attocube Systems, Montana Instruments, Quantum Design, ICE Oxford, Cryogenic Limited, Bluefors, Cryoquip, CryoMAgnetics, Vacree Technologies
North America was the largest region in the cryostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cryostat market during the forecast period. The regions covered in the cryostat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cryostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cryostat market consists of sales of single compressor, double compressor, rotary cryostat, and motorized cryostat. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The cryostat market is segmented into single compressor, double compressor, rotary cryostat and other cryostats.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cryostat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cryostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cryostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cryostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
